Wellous
HomeMeRewardsReviewsProfilePolicy NoticeTerms & Conditions

如何参加wellfarm club,請大家提供,谢谢你

如何参加wellfarm club,請大家提供,谢谢你

Suggested For You

营养早餐让你的每一天都从健康开始!

营养早餐让你的每一天都从健康开始!

尤其是碳水、水果和蛋白质在健康早餐里必不可少。🥖🥝🥛

快来瞧瞧以下的搭配建议,帮助你轻松制作出美味又营养的早餐,让我们开启幸福的每一天吧!💪😎☀️

Thinking of keeping fit?

Thinking of keeping fit?

Look no further than this secret Japanese ingredient.

Let us unshroud the mysteries of the health-potent KUROZU black vinegar.

谁能想到,小小的葡萄籽竟藏着如此强大的力量!🍇 😍葡萄籽富含高浓度原花青素,是一种天然抗氧化剂,其抗氧化效果甚至超越绿茶和蓝莓。

谁能想到,小小的葡萄籽竟藏着如此强大的力量!🍇 😍葡萄籽富含高浓度原花青素,是一种天然抗氧化剂,其抗氧化效果甚至超越绿茶和蓝莓。

想延缓衰老、提升免疫力?💜趁着这个特别的月份,选择BIO-GRAPE Seed 葡萄籽精华!含有高达95%的原花青素,助你焕发美丽,维持健康活力!🤗

Struggling to get a good night's rest? 😴 Your body needs quality sleep to recharge and tackle the day ahead. Introducing RELAZZ Sleep Enhancement Beverage, solution to free, restful night! 🌙

Struggling to get a good night's rest? 😴 Your body needs quality sleep to recharge and tackle the day ahead. Introducing RELAZZ Sleep Enhancement Beverage, solution to free, restful night! 🌙

Packed with Lactium® Milk Protein Hydrolysate to ease stress and help you to sleep better! Plus, the natural power of Fermented Rice Germ Extract reduces insomnia and uplifts your mood! Conquer stress, sleep better, and wake up refreshed with RELAZZ today! 💜💚

Did You Know?🤔 Nearly 40% of Malaysian adults have non-alcoholic fatty liver disease (NAFLD), the most common liver issue in the country.

Did You Know?🤔 Nearly 40% of Malaysian adults have non-alcoholic fatty liver disease (NAFLD), the most common liver issue in the country.

Our latest newsletter dives deep into understanding liver health! You'll explore a range of common liver conditions, the ways to prevent viral hepatitis and fatty liver, and our featured products - LIVETAL & HOMEGA to support your liver health. Also, don't miss out on our Digital Detox Challenge to give your mind and body a break!🧡✨

Click the link below to access the full newsletter and learn more about keeping your liver healthy!🥰

👉 https://cdn.wellous.com/membership/article/newsletter/2024/2024-q2-en.pdf